BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) Stock Fundamental Analysis
Europe - FRA:BRYN - US0846707026 - Common Stock
413.6 EUR
+1.95 (+0.47%)
BRYN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 46 industry peers in the Financial Services industry. BRYN has only an average score on both its financial health and profitability. BRYN may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make BRYN suitable for value investing!
1. Profitability
1.1 Basic Checks
BRYN had positive earnings in the past year.
BRYN had a positive operating cash flow in the past year.
Of the past 5 years BRYN 4 years were profitable.
Each year in the past 5 years BRYN had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 5.41%, BRYN is in the better half of the industry, outperforming 73.91% of the companies in the same industry.
BRYN has a Return On Equity (9.42%) which is in line with its industry peers.
Looking at the Return On Invested Capital, with a value of 4.37%, BRYN is in line with its industry, outperforming 52.17% of the companies in the same industry.
BRYN had an Average Return On Invested Capital over the past 3 years of 4.13%. This is significantly below the industry average of 10.06%.
The last Return On Invested Capital (4.37%) for BRYN is above the 3 year average (4.13%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.41% | ||
| ROE | 9.42% | ||
| ROIC | 4.37% |
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
1.3 Margins
With a decent Profit Margin value of 17.00%, BRYN is doing good in the industry, outperforming 65.22% of the companies in the same industry.
In the last couple of years the Profit Margin of BRYN has declined.
With a Operating Margin value of 15.70%, BRYN perfoms like the industry average, outperforming 58.70% of the companies in the same industry.
In the last couple of years the Operating Margin of BRYN has grown nicely.
BRYN has a worse Gross Margin (16.97%) than 65.22% of its industry peers.
BRYN's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.7% | ||
| PM (TTM) | 17% | ||
| GM | 16.97% |
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BRYN is creating some value.
Compared to 1 year ago, BRYN has less shares outstanding
Compared to 5 years ago, BRYN has less shares outstanding
Compared to 1 year ago, BRYN has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.43, we must say that BRYN is in the distress zone and has some risk of bankruptcy.
BRYN has a Altman-Z score of 1.43. This is comparable to the rest of the industry: BRYN outperforms 45.65% of its industry peers.
The Debt to FCF ratio of BRYN is 15.44, which is on the high side as it means it would take BRYN, 15.44 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 15.44, BRYN is not doing good in the industry: 65.22% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.19 indicates that BRYN is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.19, BRYN is doing good in the industry, outperforming 63.04% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 15.44 | ||
| Altman-Z | 1.43 |
ROIC/WACC1.36
WACC3.22%
2.3 Liquidity
BRYN has a Current Ratio of 1.95. This is a normal value and indicates that BRYN is financially healthy and should not expect problems in meeting its short term obligations.
BRYN has a better Current ratio (1.95) than 73.91% of its industry peers.
BRYN has a Quick Ratio of 1.68. This is a normal value and indicates that BRYN is financially healthy and should not expect problems in meeting its short term obligations.
BRYN's Quick ratio of 1.68 is fine compared to the rest of the industry. BRYN outperforms 76.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.95 | ||
| Quick Ratio | 1.68 |
3. Growth
3.1 Past
BRYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.24%, which is quite good.
The Earnings Per Share has been growing by 17.78% on average over the past years. This is quite good.
Looking at the last year, BRYN shows a small growth in Revenue. The Revenue has grown by 0.01% in the last year.
Measured over the past years, BRYN shows a small growth in Revenue. The Revenue has been growing by 7.84% on average per year.
EPS 1Y (TTM)8.24%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%-3.87%
Revenue 1Y (TTM)0.01%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%-1.22%
3.2 Future
The Earnings Per Share is expected to grow by 2.26% on average over the next years.
The Revenue is expected to grow by 4.89% on average over the next years.
EPS Next Y-3.47%
EPS Next 2Y0.07%
EPS Next 3Y2.03%
EPS Next 5Y2.26%
Revenue Next Year0.77%
Revenue Next 2Y0.48%
Revenue Next 3Y1.6%
Revenue Next 5Y4.89%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 0.02, the valuation of BRYN can be described as very cheap.
Based on the Price/Earnings ratio, BRYN is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
BRYN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.20.
BRYN is valuated cheaply with a Price/Forward Earnings ratio of 0.01.
BRYN's Price/Forward Earnings ratio is rather cheap when compared to the industry. BRYN is cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.71, BRYN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.02 | ||
| Fwd PE | 0.01 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BRYN indicates a rather cheap valuation: BRYN is cheaper than 97.83% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, BRYN is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 0.09 | ||
| EV/EBITDA | 0.34 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0
EPS Next 2Y0.07%
EPS Next 3Y2.03%
5. Dividend
5.1 Amount
BRYN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:BRYN (9/17/2025, 10:04:11 AM)
413.6
+1.95 (+0.47%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)
Earnings (Next)
Inst Owners33.77%
Inst Owner ChangeN/A
Ins Owners36.68%
Ins Owner ChangeN/A
Market Cap595.58M
Analysts80
Price Target453.75 (9.71%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.8%
Min EPS beat(2)-9.78%
Max EPS beat(2)0.19%
EPS beat(4)2
Avg EPS beat(4)5.7%
Min EPS beat(4)-10.41%
Max EPS beat(4)42.8%
EPS beat(8)6
Avg EPS beat(8)8.53%
EPS beat(12)8
Avg EPS beat(12)6.49%
EPS beat(16)11
Avg EPS beat(16)7.41%
Revenue beat(2)0
Avg Revenue beat(2)-3.21%
Min Revenue beat(2)-4.09%
Max Revenue beat(2)-2.33%
Revenue beat(4)0
Avg Revenue beat(4)-3.53%
Min Revenue beat(4)-7.69%
Max Revenue beat(4)-0.01%
Revenue beat(8)3
Avg Revenue beat(8)-1.26%
Revenue beat(12)4
Avg Revenue beat(12)-0.85%
Revenue beat(16)5
Avg Revenue beat(16)-1.25%
PT rev (1m)-1.63%
PT rev (3m)-3.82%
EPS NQ rev (1m)2.89%
EPS NQ rev (3m)13.05%
EPS NY rev (1m)2.72%
EPS NY rev (3m)2.36%
Revenue NQ rev (1m)-0.61%
Revenue NQ rev (3m)-2.37%
Revenue NY rev (1m)3.38%
Revenue NY rev (3m)-0.85%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.02 | ||
| Fwd PE | 0.01 | ||
| P/S | 0 | ||
| P/FCF | 0.09 | ||
| P/OCF | 0.03 | ||
| P/B | 0 | ||
| P/tB | 0 | ||
| EV/EBITDA | 0.34 |
EPS(TTM)26753.68
EY6468.49%
EPS(NY)27982.01
Fwd EY6765.48%
FCF(TTM)4837.64
FCFY1169.64%
OCF(TTM)16122.7
OCFY3898.14%
SpS217709.24
BVpS392886.64
TBVpS322648
PEG (NY)N/A
PEG (5Y)0
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.41% | ||
| ROE | 9.42% | ||
| ROCE | 5.42% | ||
| ROIC | 4.37% | ||
| ROICexc | 4.82% | ||
| ROICexgc | 5.84% | ||
| OM | 15.7% | ||
| PM (TTM) | 17% | ||
| GM | 16.97% | ||
| FCFM | 2.22% |
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
ROICexc(3y)4.31%
ROICexc(5y)3.94%
ROICexgc(3y)5.19%
ROICexgc(5y)4.78%
ROCE(3y)5.11%
ROCE(5y)4.61%
ROICexcg growth 3Y9.15%
ROICexcg growth 5Y4.04%
ROICexc growth 3Y9.9%
ROICexc growth 5Y4.98%
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
F-Score4
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 15.44 | ||
| Debt/EBITDA | 1.78 | ||
| Cap/Depr | 146.66% | ||
| Cap/Sales | 5.18% | ||
| Interest Coverage | 11.47 | ||
| Cash Conversion | 38.5% | ||
| Profit Quality | 13.07% | ||
| Current Ratio | 1.95 | ||
| Quick Ratio | 1.68 | ||
| Altman-Z | 1.43 |
F-Score4
WACC3.22%
ROIC/WACC1.36
Cap/Depr(3y)148.32%
Cap/Depr(5y)138.32%
Cap/Sales(3y)5.18%
Cap/Sales(5y)5.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.24%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%-3.87%
EPS Next Y-3.47%
EPS Next 2Y0.07%
EPS Next 3Y2.03%
EPS Next 5Y2.26%
Revenue 1Y (TTM)0.01%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%-1.22%
Revenue Next Year0.77%
Revenue Next 2Y0.48%
Revenue Next 3Y1.6%
Revenue Next 5Y4.89%
EBIT growth 1Y6.42%
EBIT growth 3Y18.52%
EBIT growth 5Y13.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-68.47%
FCF growth 3Y-23.7%
FCF growth 5Y-12.55%
OCF growth 1Y-36.42%
OCF growth 3Y-8.11%
OCF growth 5Y-4.59%